Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Here we report an activity-dependent stabilization of the MAP kinase (MAPK) pathway, prominent in hippocampal dendrites. The longevity of the signal in these dendrites was increased to hours when ...

Achieved $61.5 million and $172.0 million in fourth quarter and full year 2024 OGSIVEO® (nirogacestat) U.S. net product revenues, respectively ...

Aberrant activation of the Ras/Raf/MAPK/ERK kinase/extracellular signal-regulated kinase cascade and the VEGF pathway are commonly observed in breast cancer cells leading to malignant cell ...

Weave , a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses, today announced that its Chief Financial Officer, Alan Taylor, plans ...

Exelixis, Inc. today announced that the company's Board of Directors has authorized the repurchase of up to an additional $500 million of the company's common stock before December 31, 2025. Exelixis ...

Gain-of-function mutations in fibroblast growth factor receptor (FGFR) genes are known to cause a range of skeletal disorders ...

According to a new study published in the journal Cellular Signalling, cannabinoids may play a crucial role in preventing and treating brain diseases by regulating key physiological processes in the ...

A newly identified part of a brain circuit mixes sensory information, memories, and emotions to tell whether things are ...

Researchers from the National University of Singapore (NUS) have pioneered a new catalytic transformation that converts ...

Researchers combined animal models, human brain tissue, and molecular analysis to uncover a connection between Alzheimer's ...

Artificial Intelligence - two words that spark equal parts excitement and existential dread. But what exactly is AI? Is it the unseen force behind your eerily well-timed online ads? The chatbot ...